Queensland company XXXX is adding another drink to its shelf with the launch of its first alcoholic ginger beer. Picture: Supplied XXXX field director Pat Donohue said the Queensland company ...

Conversely, 1,25 VD3 supplementation alleviated liver damage, reducing liver enzymes and improving histopathological features characteristic of non-alcoholic steatohepatitis ... transaminase (AST) and ...

AST SpaceMobile (NASDAQ: ASTS) stock fell 3.2% through 10:10 a.m. ET Tuesday on some disconcerting news out of the Securities and Exchange Commission (SEC). In a trio of stock filings Monday, AST ...

AstraZeneca will leverage Alteogen’s platform technology to develop the therapies. Credit: © AstraZeneca 2025. AstraZeneca has entered an exclusive licence ...

A standard drink is a measure of how much pure alcohol you are drinking. It varies based on the concentration of alcohol in a beverage. In Canada, a standard drink is 17.05 millilitres or 13.45 grams ...

07:47 EDT AST SpaceMobile (ASTS) files to sell 56.1M shares of common stock for holders Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor ...

The company unveiled plans last week to test its GLP-1/glucagon dual receptor agonist in alcohol use disorder and alcohol-related liver disease. Altimmune is reportedly being pursued by three ...

Ahead of the report, analysts had been forecasting that AST would say it had lost $0.18 per share in Q4 on revenue of $2.4 million. AST did in fact lose $0.18 per share, but its revenue was only ...

Evercore ISI likes the expansion of pemvidutide into alcohol liver disease and alcohol use disorder as it adds another leg to the pemvidutide story and one that Altimmune (ALT) can take the lead in.

Reserve your spot now. Altimmune Inc ALT hosted a virtual R&D day on Thursday, marking the first disclosure of Alcohol Use Disorder (AUD) and Alcohol Liver Disease (ALD) as potential developments ...